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Abstract
Background: Nurse prescribing of medicines is increasing worldwide, but there is limited research in Europe. The
objective of this study was to analyse which countries in Europe have adopted laws on nurse prescribing.
Methods: Cross-country comparative analysis of reforms on nurse prescribing, based on an expert survey
(TaskShift2Nurses Survey) and an OECD study. Country experts provided country-specific information, which was
complemented with the peer-reviewed and grey literature. The analysis was based on policy and thematic analyses.
Results: In Europe, as of 2019, a total of 13 countries have adopted laws on nurse prescribing, of which 12 apply
nationwide (Cyprus, Denmark, Estonia, Finland, France, Ireland, Netherlands, Norway, Poland, Spain, Sweden, United
Kingdom (UK)) and one regionally, to the Canton Vaud (Switzerland). Eight countries adopted laws since 2010. The
extent of prescribing rights ranged from nearly all medicines within nurses’ specialisations (Ireland for nurse
prescribers, Netherlands for nurse specialists, UK for independent nurse prescribers) to a limited set of medicines
(Cyprus, Denmark, Estonia, Finland, France, Norway, Poland, Spain, Sweden). All countries have regulatory and
minimum educational requirements in place to ensure patient safety; the majority require some form of physician
oversight.
Conclusions: The role of nurses has expanded in Europe over the last decade, as demonstrated by the adoption of
new laws on prescribing rights.
Keywords: Health professionals, Nurses, Prescribing, Medications, Laws, Reforms, Advanced practice nursing (APN),
Task shifting, Scope of practice
Background
The right to prescribe medications has for long been re-
served to the medical profession only. This situation has
changed, with an increasing number of countries worldwide
having introduced reforms to authorise nurses to prescribe
certain medications [1–6]. The United States of America
(US) and Canada have a long tradition with nurses working
in advanced practice roles, which includes the right to pre-
scribe medicines [7–9]. Common drivers that led to nurse
prescribing reforms include physician shortages (e.g. in
rural areas), the rise in chronic conditions, more interpro-
fessional team work and an increase in nursing education
at higher educational institutions [1, 3, 10]. Introducing
new roles for nurses has been referred to as a disruptive
innovation in healthcare [11]. Advanced nursing roles
have shown to have implications not only for the nurses
and the teams in which they practice and are influenced by
policies and regulatory mechanisms [12, 13]. For instance,
changes to scope-of-practice laws and policies on advanced
educational programmes have shown to facilitate the up-
take of nurse prescribing and other advanced practice nurs-
ing roles [12–14].
Nurse prescribing refers to the official right granted to
nurses to prescribe certain medications [4, 15]. The ex-
tent of nurse prescribing depends on several factors:
first, the groups of nurses authorised to prescribe, which
can range from small, highly specialised groups of nurses
to all professional nurses; second, the type of medica-
tions that nurses are allowed to prescribe, which can
range from all medicines to a restricted set; and third,
the overall legal responsibility, ranging from independent
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prescribing to a delegated model under the supervision
of a physician [15–17]. Nurse prescribing has been
shown to be comparable to physicians’ prescribing prac-
tices, as measured by the number of medications pre-
scribed as well as the types and doses of the medications
chosen [6, 18, 19]. Patients were similarly satisfied or
more satisfied with nurses than physicians [18]. A
Cochrane systematic review showed that nurses were as
effective in prescribing medications as physicians for a
range of conditions including chronic diseases [19].
An international survey in ten high-income countries
(Australia, Canada, Finland, Ireland, the Netherlands,
New Zealand, Spain, Sweden, the United Kingdom and
the US) showed that the educational and legal condi-
tions varied across countries [1]. Among high-income
countries worldwide, Australia, Canada, New Zealand
and the US are commonly cited as having implemented
laws granting the prescribing of a wide range of medi-
cines to advanced practice nurses (APN) with a Master’s
degree [1, 2]. APN in these countries are authorised to
prescribe all or almost all medicines within their spe-
cialty. However, differences exist in the regulation of
nurse prescribing, namely if collaborative agreements
with physicians are required by law [6, 20, 21]. In
addition, in Australia, Canada and New Zealand, there
have also been recent developments to grant registered
nurses limited prescribing rights [21, 22].
In Europe, the United Kingdom (UK) has a long ex-
perience with nurse prescribing [6], where two models
of nurse prescribing originated [15, 23], independent
and supplementary nurse prescribing. While the former
model grants the nurses the authority to issue prescrip-
tions independently including initial prescribing of a
medicine for the first time, the latter model refers to the
continued prescribing after a diagnosis and treatment
plan has been made by a physician [15, 23]. Research on
nurse prescribing reforms has been limited and mostly
focused on selected topics and individual countries, such
as in the UK and Ireland on prescribing practices and
safety considerations [24, 25] as well as factors enabling
implementation of reforms in Ireland [26]. Recently, re-
search in the Netherlands has evaluated task shifting be-
tween physicians and nurse specialists with generally
positive results [27, 28]. Research in the Netherlands
also assessed physicians’ and nurses’ views of introdu-
cing nurse prescribing [23] as well as prescribing prac-
tices of nurses in hospitals, which were shown to be
influenced by national policies as well as individual hos-
pital governance structures [29]. From an international,
cross-country perspective, research on nurse prescribing
reforms and the extent of prescribing authority of medi-
cines has been scarce. One exception is a review by
Kroezen et al. [1]. The review covered 10 countries of
which six belong to the European Union (Finland,
Ireland, the Netherlands, Spain, Sweden, and the United
Kingdom). It showed that at the time of data collection,
three countries (Finland, Spain, the Netherlands) were in
the process of introducing legislation, suggesting an up-
date of the current state of these reforms is warranted.
Moreover, no study to date has systematically covered
all countries belonging to the EU’s single market.
The purpose of this study was to analyse which coun-
tries in Europe have introduced nurse prescribing reforms,
the extent of prescribing and regulations in place. Cover-
ing all countries belonging to the EU’s single market is of
relevance for its free movement principle across borders
which also applies to health professionals. For the nursing
profession, the first-level education as professional nurse
is automatically recognised, yet no nurse specialisations
are covered under the EU regulation [30, 31].
Methods
The study was based on an expert survey to identify
which countries in Europe have implemented reforms
on nurse prescribing of medicines and, in those coun-
tries with reforms, an analysis of the extent of prescrib-
ing authority, regulatory and oversight requirements.
Expert survey to identify countries with prescribing
reforms
An expert survey was conducted in 39 countries (Task-
Shift2Nurses Study) in 2015 covering all EU Member
States and countries belonging to the EU’s single mar-
ket, plus Australia, Canada, New Zealand and the US.
A total of 93 country experts participated (response
rate 85.3%). The sampling was based on two interre-
lated strategies: snowballing and network strategies to
counteract the weaknesses associated with snowballing
alone, which has been associated with selection bias or
too homogeneous groups [2]. The selection process of
the country experts followed two stages: first, five inter-
national health workforce experts were identified and
contacted to provide names of country experts. In a
second step, the suggested names were reviewed and
contacted if in accordance with a list of pre-defined cri-
teria (e.g. senior position related to nursing either in
academia, at national nursing association, Ministry of
Health, relevant publications on the topic, proficiency
in English). More details about the methodology are
available elsewhere [2]. Among the questions covered
in the survey were if nurses were authorised to pre-
scribe medications and related reforms implemented or
ongoing, as of 2015.
Analysis of country reforms on nurse prescribing
Of those countries identified with reforms on nurse pre-
scribing, an in-depth analysis of laws and policy documents
was performed as part of an Organisation for Economic
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Cooperation and Development (OECD) study. Country ex-
perts were contacted in 2016 for the purpose of the OECD
study on nurses in advanced roles of which prescribing of
medicines was one example [4]. A total of 25 country ex-
perts from those countries with nurse prescribing reforms
implemented or ongoing were contacted and 21 partici-
pated (response rate 84%). They provided additional infor-
mation on the laws, the extent of prescribing rights (e.g. for
which medicines and health conditions), educational, regu-
latory and oversight requirements in the countries. For the
purpose of this paper, the country experts were again con-
tacted in 2019 to inquire if the information provided in
2016 was still up to date. A total of 15 experts participated
in the 2019 round (response rate 60%) and provided up-
dates to pre-filled forms based on the 2016 data collection.
In five cases, there was a lack of clarity on specific issues,
which was then followed up via e-mail or phone calls and
resolved through discussion.
In addition, a literature search was conducted with a
search of the peer-reviewed (PubMed, CINAHL, Google
Scholar) and grey literature (websites of International
Council of Nurses, European Federation of Nurses,
WHO, OECD, national Ministries of Health). Search
terms covered a set of terms combined with Boolean op-
erators on nurses (e.g. registered nurse, professional
nurse, nurse specialist, Advanced Practice Nurse, Nurse
Practitioner and other titles and combinations), prescrib-
ing (prescri*) and the names of the 28 EU countries plus
Norway and Switzerland.
The analysis was based on thematic analyses of the laws,
policy documents and other grey material, focussing on
the content of the laws, by-laws and the educational and
regulatory requirements if stipulated in other legal docu-
ments. The analyses were structured according to the
groups of nurses authorised to prescribe, by medicines
used for the prevention or treatment of major conditions
to assess the extent of prescribing, differentiating between
initial prescribing (IP) and continued prescribing (CP)
only. Finally, additional requirements were analysed by
country and groups of nurses, including mandatory regis-
tration requirements (e.g. in a registry), levels of physician
oversight and other oversight requirements. The analysis
was performed by the author using standardised word ta-
bles based on the survey responses, complemented with
information from the laws and legal documents and fed
back to the country experts as part of the 2019 round
where experts were requested to provide updates of the
information or confirm that the information was up to
date.
Results
As of 2019, 13 countries in Europe have laws on nurse
prescribing in place, which apply nationwide in 12
countries (Cyprus, Denmark, Estonia, Finland, France,
Ireland, Netherlands, Norway, Poland, Spain, Sweden,
United Kingdom) and in one region in Switzerland in
the Canton Vaud (Table 1).
The four nations of the UK and Sweden were the first
countries in Europe which introduced prescribing rights
dating back to 1992 and 1994, respectively. Countries
that followed were Norway, Ireland and Denmark in
2002, 2007 and 2009. Since 2010, eight additional coun-
tries (including the Canton Vaud, Switzerland) have
authorised specific groups of nurses to prescribe certain
medications. All have adopted laws to officially grant
nurses prescribing rights, in some cases followed by the
adoption of decrees to define under which conditions
nurses are allowed prescribe, for what medications and
the regulatory requirements.
The countries vary considerably in the groups of
nurses that are authorised to prescribe and their educa-
tional requirements: a first group consists of countries in
which the prescribing skills and competencies are part
of the nurses’ education, e.g. Master’s or Bachelor’s de-
grees or specific nurse specialisations. Hence, the pre-
scribing skills and competencies are directly integrated
in these curricula, e.g. ANP Master nurses in Cyprus,
Nurse Specialists with APN degree in the Netherlands,
Public Health Nurses in Norway, nurses with Master’s
and Bachelor’s degree in Poland, family nurses in
Estonia; and nurses with a Bachelor’s degree in Spain.
Since courses on pharmacology and pharmacotherapy
are routinely part of these curricula, it was only in a few
cases possible to single out how many European Credit
Transfer Systems (ECTS) points are allocated specifically
on skills and competencies related to the prescribing of
medicines. For instance, in Cyprus, the curriculum of
APN Master-level nurses comprises advanced pharma-
cology and pharmacotherapy of approx. six ECTS. In
Denmark, prescribing is taught as part of a 30 ECTS
“cluster” on medical treatment and therapy. In the
Netherlands, RNs with a specialisation in diabetes and
RNs with a specialisation of lung care are required to
have a minimum of 2.5 ECTS on prescribing in their
curriculum [32].
Second, some countries have set up a separate educa-
tional pathway specifically on nurse prescribing, hence,
additional educational courses which lead to a title as
nurse prescriber or similar. The countries are Finland,
Ireland and the UK. The UK has introduced two models
of prescribing, independent and supplementary pre-
scribers. Ireland and Finland have established one role.
Educational requirements vary, they range between
typically 30 to 45 UK credits in the UK, 20 to 40 ECTS
in Ireland and mandatory 45 ECTS in Finland. In 2019,
the UK Nursing and Midwifery Council has published
new standards for the post-registration programmes
which apply since September 2019 [46].
Maier Human Resources for Health           (2019) 17:95 Page 3 of 10
France and the Swiss Canton Vaud are in the process
of implementing the 2017 laws on nurse prescribing,
pending the agreement of formularies and other mini-
mum requirements as a prerequisite for nurses to offi-
cially being authorised to prescribe medicines.
Extent of prescribing rights
Table 2 shows the extent of prescribing rights by coun-
try. The countries vary considerably in the number of
medicines which nurses are officially allowed to pre-
scribe, for which diseases and the type of prescribing.
The type of prescribing refers to initial and continued
prescribing, of which the former is the right to newly
prescribe medicines, whereas the latter refers to follow-
up prescriptions after the diagnosis and first prescription
has been issued by a physician.
Three of the 13 countries have granted full or nearly full
prescribing rights to a specific group of nurses. The coun-
tries are Ireland (nurse prescribers), the Netherlands
(nurse specialists) and the UK (independent nurse pre-
scribers). These groups of nurses are by law allowed to
prescribe any medicine within their specialty. In the UK
and Ireland, the extent of prescribing was expanded grad-
ually over time. In the UK, the law was changed in 2006
authorising independent prescribers full access to the Brit-
ish National Formulary granting the same prescribing
rights as for physicians, and subsequently in 2012 to cover
certain controlled drugs [16]. In Ireland, nurse prescribers
can prescribe a full set of medicines since 2007, including
certain controlled drugs. In the Netherlands, an initially
time-limited law was introduced in 2012, linked to a na-
tionwide evaluation. The law granted nurse specialists
with a Master’s degree APN full prescribing rights within
Table 1 Nurse prescribing laws, years of adoption and groups of nurses authorised to prescribe medications, 13 countries
Year first
adopted
Country Regulation Group(s) of nurses authorised to prescribe (qualification requirements)
1992 UK Medicinal Products: Prescription by
Nurses etc. Act 1992
(i) Independent prescribers (full prescribing rights since 2006; including certain
controlled drugs since 2012, course on independent nurse prescribing required
(NMC approved post-registration prescribing programme e.g. v200 or v300
course, length varies, e.g. 30–45 UK credits, typically 6 months; as of September
2019, new standards apply), this includes Community Practitioner Nurse Pre-
scribers (CPNP) with prescribing rights according to a formulary (e.g. V100 or
V150, e.g. 10 UK credits), (ii) Supplementary prescribers since 1992 (limited pre-
scribing rights, approved course as a supplementary prescriber)
1994 Sweden Law RN (Bachelor from university or university college, 180 ECTS)
2002 Norway Law Public health nurse specialisation (Bachelor, plus 60 ECTS)
2007 Ireland Pharmacy Act, Statutory Instrument No.
201/2007 on Medicinal Products
Nurse prescriber: RN plus additional, approved educational programme (range 20
to 40 ECTS for nurse prescriber certificate or higher if Master APN programme)
2009 Denmark Order 1219 of 11/12/2009 delegation of
reserved procedures
RN (Bachelor, of which 30 ECTS “cluster” on medical treatment, including
prescribing)
2010 Finland Decree 1088/2010 on Prescriptions Nurse prescriber: RN (Bachelor, with postgraduate education in prescribing (45
ECTS)
2012 Netherlands Decree, December 21/2011 Nurse specialist (Verpleegkundig Specialist) (Master APN, 120 ECTS)
2012 Cyprus Nursing and Midwifery Law, Annex III,
2b) V
APN nurse (Master APN degree with specialisation in Midwifery, ICU, Mental
Health, Oncology, Community health). Advanced pharmacology (6 ECTS) is part
of the Master APN programme
2014 Netherlands Decree of 2014 Diabetes, lung, oncology nurses (Bachelor, and completion of pharmacotherapy
course at a University of Applied Science, e.g. for diabetes and lung nurses,
curricula comprise minimum of 2.5 ECTS on prescribing
2015 Poland Ordinance of 28/10/2015 on
prescriptions issued by nurses and
midwives
Two-tiered: RN with (i) Master and (ii) Bachelor’s degree
2015 Spain Royal Decree 954/2015 of 23 October RN (Bachelor with min. 1 year work experience; or additional training in
prescribing if < 1 year experience)
2016 Estonia Health Services Organization Act 2016 Family nurse (pereõde) if working with a family doctor (pereast) with completed
training of 120 hours (clinical pharmacology, approved by the Agency of
Medicines)
2017 France Act 2016-41 on the modernisation of
the health system
Nurse (“Medical auxillaires”)
2017 Switzerland
(Vaud)
Article 124b of Public Health Act 800.01 Nurse specialist (Master) (“Infirmier practicien spécialisé”)
ANP advanced nursing practice, APN advanced practice nurse, CPD continuous professional development, RN registered nurse, sources: [16, 32–45]
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their specialty. After a generally positive evaluation, the
time-limited nature of the law was changed to unlimited
duration in September 2018 [27].
In the remainder countries, the extent of prescribing is
limited, either in the number of medicines that nurses are
by law allowed to prescribe or in the type of prescribing,
allowing primarily or exclusively continued prescribing. In
the Netherlands (Bachelor nurses with a specialisation in
either diabetes, lung or oncology), Norway (public health
nurses), Poland (Master level) and Sweden (Bachelor
level), nurses are authorised to initially prescribe certain
medicines from a limited set of medicines (Table 2). In
the Netherlands, the three Bachelor-level nurse specialisa-
tions are authorised to initially prescribe a limited number
of medicines within their specialty (prescription-only
medications), after a diagnosis has been made by a phys-
ician, and as specified within protocols and standards. In
Norway, public health nurses work in child health clinics
and frequently in schools or youth health centres where
they provide health counselling including on sexual health
and prescribe contraceptives [47]. Public health nurses
can officially prescribe all contraceptives for all women
Table 2 Extent of nurse prescribing, by group(s) of nurses and country
Prescribing rights by major areas and conditions (IP = initial prescribing, CP = continued prescribing only)
Country Name/title of
nurses
Vaccines Contraceptives Chronic
conditions
Acute illnesses Pain medication Other
Full prescribing rights (within specialty)
Ireland Nurse
prescriber1
IP IP IP IP IP IP
Netherlands
Nurse
Specialist2
IP IP IP IP IP IP
UK Independent
prescriber1
IP IP IP IP IP IP
Limited prescribing rights
Denmark Registered
Nurse3
CP CP CP CP CP CP
Estonia Family nurse
(pereõde)
– CP (hormonal
contraceptive)
CP (diabetes,
hypertension)
CP (acute cystitis,
nitrofurantoiin)
– –
Finland Nurse
prescriber
IP (influenza,
hep.,
varicella^)
IP (hormonal
contraceptive^#)
CP (asthma,
dyslipidemia,
T2D,
hypertension)^
IP (pharyngitis)^,
CP (UTI)^
IP (e.g. local
anaesthetics)^
–
Netherlands
Diabetes, lung,
oncology
nurses
– – IP (diabetes,
oncology, lung
diseases)
– IP (oncology) –
Norway Public Health
Nurse
IP IP (including
IUD)a
– – IP (adrenaline for
allergic reaction,
local anaesthetics)
IP (sterile
equipment for IU,
implants, STD kits)
Poland RN (Master) – IP
(gynaecological
drugs)
IP (asthma, e.g.
bronchodilators)
IP (throat, ear,
sinus, UTI)
IP (analgesics,
locally acting
anaesthetics)
IP (anti-emetics,
anti-parasitic, IV
infusion fluids)
Poland RN (Bachelor) 4 – CP (as above) CP (as above) CP (as above) CP (as above) CP (as above)
Spain RN (Bachelor)5 IP (according
to vaccination
schedule)
IP (emergency
contraception)
CP CP CP IP (OTC)
Sweden RN (Bachelor) – – – IP (throat, mouth,
dermatological
disease, GI, UTI)
IP (pain
management)
–
UK Supplementary
prescriber
CP CP CP CP CP CP
Cyprus, France, Switzerland (Vaud): not listed because no information available on the medicines/formulary, IP initial prescribing (prescribing right of a new
medicine/product), CP continuous prescribing (follow-up prescribing after first prescription issued by physician), n/r not reported (in the law/regulations, “-“ not
authorised to prescribe any medicine/product in the area, n/a no information available, OTC over-the-counter medicines, Hep. hepatitis, UTI urinary tract infection,
GI grastrointestinal. 1Initial prescribing rights of all medicines falling within nurses’ specialty, restrictions and additional requirements apply to controlled drugs
(e.g. UK: controlled drugs except for cocaine, dipipanone or diamorphine for treating addiction), 2Netherlands = initial prescribing rights of all medicines falling
within nurses within nurse specialists’ specialty, Cyprus = details on the types of medicines/substances not (yet) specified in law; ^not for children under the age
of 12, #not for women under age 35, aonly for women over 16 years of age, 3Denmark = continued prescribing according to local frame prescriptions and in a
delegated model, 4Poland: prescribing rights according to formulary of 12 groups of medicines, 5Spain: prescribing rights granted to all RN with minimum 1 year
work experience; for RN with less than 1 year work experience, additional training required
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aged 16 years and over. In one study, public health nurses
wrote more prescriptions than physicians for young
women aged 17–18 years [47].
A mix of initial and continued prescribing exists in
Finland and Spain; it includes initial prescriptions of vac-
cines and contraceptives in Finland and Spain and follow-
up medications for highly prevalent chronic and acute con-
ditions. In Denmark (Bachelor), Estonia (family nurse),
Poland (Bachelor) and the UK (supplementary prescribers),
nurses are authorised to perform continued prescribing, ac-
cording to patient management plans and in a delegated
model.
No information on the details of prescribing rights was
identified for Cyprus, France and the Canton Vaud
(Switzerland). In Cyprus, there is no information pro-
vided in the 2012 law on what medicines the Master
APN nurses are allowed to prescribe. The law states that
medicines from a list can be prescribed by nurses, but
with no further information. In France and Vaud, due to
the adoption of the laws in 2017, developments are on-
going to specify which medications nurses will be able to
prescribe.
Regulatory and oversight requirements
All countries have defined regulatory requirements as a
pre-condition for nurses to prescribe medications
(Table 3). The reason is the highly specialised nature of
prescribing. The majority of countries require some
form of additional registration as a prescriber in a regis-
try or a prior authorisation by a competent authority.
Several countries added additional regulatory require-
ments, e.g. in Ireland, UK and Finland, nurse prescribers
receive a unique ID number to facilitate the identifica-
tion of who prescribes what medication. In addition,
most countries require some form of official authorisa-
tion, contract, collaboration, agreement or official super-
vision by an individual physician (Denmark, Estonia,
Finland, Ireland, Spain, UK).
Discussion
This study shows that in Europe, certain groups of
nurses are officially authorised to prescribe medications
in 13 countries (nationwide in 12 countries and in one
region in Switzerland, Canton Vaud). The majority of
the reforms have been introduced over the past decade.
Since 2010 alone, eight of the 13 countries newly intro-
duced nurse prescribing (Finland, Netherlands, Cyprus,
Estonia, Poland, Spain, France and the region Vaud in
Switzerland). Hence, nurse prescribing has been a recent
development in several countries in Europe. The extent
of prescribing rights varies considerably, with three
countries (Ireland, Netherlands, UK) granting certain
groups of nurses (nurse prescribers, nurse specialists, in-
dependent nurse prescribers, respectively) almost full
prescribing authority within their specialty. In the other
countries, the number of medications is restricted, de-
fined in a formulary or can be prescribed only after an
initial prescription has been made by a physician. All
countries have regulated the conditions under which
nurses are allowed to prescribe; the majority require
additional registration in the prescribing function, some
form of physician oversight and other measures to en-
sure patient safety.
The study faces several limitations. First, it has exclu-
sively focused on nurse prescribing; however, some of
the countries have also introduced prescribing for other
non-medical professions, such as midwives or pharma-
cists. Second, while the article provides an overview of
the groups of nurses and extent of prescribing rights, the
exact types and doses of medicines were not covered in-
depth and should be investigated in future research.
Third, information on educational requirements for
nurse prescribing was difficult to obtain, particularly for
countries where nurse prescribing is integrated in basic
or advanced educational programmes.
The findings are largely consistent with previous re-
search [1, 3, 4] and provide an update with more
European countries covered and recent reforms included.
While several studies in the past have focused on Anglo-
Saxon countries, with Ireland and the UK frequently cov-
ered in research [10, 15], this study has enabled to cover
more European countries. This study shows that the ex-
tent of nurse prescribing varies considerably across the
countries studied and for specific groups of nurses within
three countries (Netherlands, Poland, UK), which is con-
sistent with the previous literature (ibid). Most countries
in this study restricted prescribing rights to a list of medi-
cines with regulatory requirements including physician
oversight. In previous research, due to the differences in
country coverage, which covered six European countries
(Finland, Ireland, Netherlands, Spain, Sweden, UK) and
Australia, Canada, New Zealand and the United States,
the findings showed higher levels prescribing rights and
independence in prescribing, e.g. for advanced practice
nurses [1, 17].
The findings of this study show that there are high
variations in the educational requirements, ranging from
Bachelor level (e.g. Denmark, Spain, Sweden) to Master
level degrees (e.g. Cyprus, Netherlands, Poland). There
was no obvious link between the extent of prescribing
rights and the length and level of training across the
countries. In the three countries with almost full pre-
scribing rights, educational requirements also varied. In
the Netherlands, nurse specialists are required to hold a
Master’s degree (120 ECTS) as a prerequisite to pre-
scribe medicines. In Ireland and the UK, the competen-
cies are taught in prescriber courses that are approved
by the competent authorities, but the length varies and a
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Master’s degree is not required. There is a paucity of re-
search linking the educational requirements with pre-
scribing practices, the quality of prescribing and patient
outcomes. While previous research has analysed the as-
sociation of higher nurse education (e.g. higher propor-
tion of Bachelor-level nurses or a higher proportion of
professional nurses among all nurses) with improved pa-
tient outcomes and mortality [48, 49], no research was
identified on the association between qualification and
prescribing outcomes.
The reforms introducing nurse prescribing in 13
countries span different health systems, educational
systems and geographic locations across Europe, in-
cluding predominantly social health insurance (France,
Netherlands) and Beveridge models (e.g. UK, Ireland).
The reasons of introducing these reforms and new
laws have not been systematically investigated across
countries. Previous research suggests several potential
drivers, including increasing patient needs and vol-
ume, higher education of nurses, higher workloads
among physicians, inefficient division of work and
high costs, among others [17]. Other research identi-
fied the roles, skills and competencies of individual
prescribers, professional boundaries, organisational
and institutional contexts as potential drivers or bar-
riers [12, 13, 50]. In Ireland, several facilitating factors
were identified as having contributed to the successful
implementation of nurse prescribing: strong advocacy
by the nursing profession, planning for nurse educa-
tion and practice, support for multiprofessional teams
and supportive government action [26]. Overall, it ap-
pears that the interplay of different factors, including
Table 3 Regulatory and oversight requirements
Country Group of nurses Registration/
authorisation
Physician oversight officially
required? (e.g. collaborative
agreement)
Other regulatory requirements (e.g. protocols, employer-
level requirements)
Cyprus APN Yes (authorisation from
competent authority)
n/r n/r
Denmark RN No Formal collaboration with a
physician
Individual frame prescriptions with physician required
Estonia Family nurse
(pereõde)
Yes (Health Board,
Healthcare Workers’
Registry)
Required to work with a
family physician
No
Finland RN Yes Authorisation by a physician Employment with municipal health center; ID number with
National Supervisory Authority for Welfare and Health
Ireland Nurse prescriber Yes (An Bord Altranais) Collaborative agreement
with a physician required
Employment in healthcare setting, personal identification
number (PIN)
Netherlands Nurse specialist Yes (nurse specialist
registry)
No No
Diabetes, lung,
oncology
specialist nurses
No (not legally required,
but voluntary
registration possible)
No Following protocols and after initial diagnosis by a
physician
Norway Public health
nurse
Yes (National registry of
healthcare professions)
No Formal documentation of prescriptions (as any other
profession), listed in central registry for prescriptions logs
Poland RN (Master) No No No
RN (Bachelor) No Continuous prescribing
only, after initial diagnosis
by physician
No
Spain RN (Bachelor) Yes (regions in charge of
issuing certificates on
prescribing)
Yes, physician supervision For certain medicines, prescribing rights to be defined in
protocols and clinical guidelines, to be developed by the
Medical and Nursing Councils and MoH
Sweden RN (Bachelor) Yes (prescribing code at
Board of Health and
Welfare)
No (e.g. if employed as
district nurse, works
independently)
Employment with county council, primary, home health or
elderly care
UK Independent
prescriber
Yes (annotation in
registry as independent
prescriber)
Prescribing partnership with
physician required
Support from employing organisation, personal
identification number
Supplementary
prescriber
Yes (annotation as
supplementary
prescriber)
Clinical management plan,
prescribing partnership with
physician
Support from employing organisation, ID number,
continued prescribing of medicines listed in individual
clinical management plan agreed between patient,
physician and supplementary prescriber
APN advanced practice nurse, MoH Ministry of Health, n/r not reported (in law/regulation), RN registered nurse. France, Canton Vaud (Switzerland): no
information available
Maier Human Resources for Health           (2019) 17:95 Page 7 of 10
nurses’ prescribing skills and education, organisational
factors as well as government, stakeholder and policy
support determine the implementation process. More-
over, reforms appear to take time. In the three
countries in our study that grant almost full prescrib-
ing rights to specific groups of nurses (Ireland,
Netherlands, UK), the policy process was lengthy and
evolved over time. In Ireland and the UK, the extent
of prescribing rights were initially limited and grad-
ually expanded over time in line with generally posi-
tive evaluations [15].
One driver often referred to in Europe is the higher edu-
cation of nurses in line with the Bologna cycle [17, 51, 52].
This may explain the occurrence of informal prescribing
practices among nurses which paved the way towards for-
malising nurse prescribing, as reported in the Netherlands
and Spain [53, 54]. In the Netherlands, this argument was
strong in the policy debate on whether to introduce a law;
controversially debated between the medical and nursing
associations [53]. Overall, there is a lack of systematic
cross-country research on the role of various influencing
factors acting as barriers or facilitators to the introduction
of nurse prescribing. In particular, more research is
needed on why nurse prescribing laws have been adopted
in the 13 European countries and not others.
In three of the 13 countries, the implementation of the
laws is ongoing, pending the adoption of regulatory de-
crees and capacity building in education. France and the
Canton Vaud have in common that the laws have been
recently adopted in 2017. In Cyprus, the year of adop-
tion was 2012. In Cyprus, there is no evidence of nurse
prescribing officially taking place in practice, as no indi-
vidual request has been made to authorise prescribing
rights.
The fact that to date 13 countries belonging to the
EU’s single market grant certain groups of nurses pre-
scribing rights demonstrates that further cross-country
research is required from an EU perspective. Research
should focus on commonalities and differences in pre-
scribers’ education across Europe, country variations in
prescribing practices as well as the extent of prescribing
rights and outcomes on specific patient groups. More-
over, with the increase in health professional mobility
across Europe, including nurses, a timely monitoring of
nurses with prescribing rights is warranted as to avoid
skills mismatches when moving borders [55–57].
Conclusions
A total of 13 countries in Europe have laws on nurse
prescribing in place, of which the majority adopted
laws over the past decade, suggesting a recent trend
expanding the roles of nurses in these countries.
The extent of prescribing rights varies considerably,
with three countries granting full prescribing rights,
whereas the majority of countries have restricted
prescribing rights, particularly those with recent re-
forms. From an EU perspective, future cross-country
research is required to monitor the education, pre-
scribing practices and mobility patterns of nurses
with prescribing qualifications.
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